Phreesia, Inc. PHR posted mixed results for the second quarter on Thursday. The company posted quarterly earnings of 1 cent per share, compared to market estimates of a loss of 6 cents per share. The company's quarterly sales came in at $117.255 million versus expectations of $116.526 million.

Q2 EBITDA guidance was raised by $2 million, roughly matching the quarterly performance beat. Needham lifts price target to $35; Piper Sandler raises target to $34. Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On Phreesia Inc.

Phreesia ( NYSE:PHR ) reported second quarter fiscal 2026 results on September 4, 2025, highlighted by its first-ever net income positive quarter and a landmark $160 million cash acquisition of AccessOne. Revenue rose 15% year over year to $117.3 million, adjusted EBITDA reached $22 million with ...

Phreesia (PHR) delivered earnings and revenue surprises of +114.29% and +0.70%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

Phreesia ( NYSE:PHR ) , a healthcare software company specializing in digital patient intake and payment solutions, reported its financial results for the quarter ended July 31, 2025, on September 4, 2025. The most notable news from the release was the company's achievement of its first-ever GAAP ...

Evaluate the expected performance of Phreesia (PHR) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.